Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

p53 gene mutation in human borderline epithelial ovarian tumors.

Journal of the National Cancer Institute - 19 Oct 1994

Wertheim I, Muto M G, Welch W R, Bell D A, Berkowitz R S, Mok S C

Abstract excerpt

No abstract is available from the source.

Topics

Carcinoma
Chromosome Deletion
Female
Genes, p53
Heterozygote
Humans
Mutation
Neoplasm Invasiveness
Ovarian Neoplasms
Polymerase Chain Reaction

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 7932812
DOI: 10.1093/jnci/86.20.1549

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 30 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

p53 gene mutation in human borderline epithelial ovarian tumors.PMID 7932812Read ↗

Genetic alterations in ovarian borderline tumours and ovarian carcinomas.Semantic proximity Read ↗

Frequency of mutations and polymorphisms in borderline ovarian tumors of known cancer genes.Semantic proximity Read ↗

p53 gene analysis of ovarian borderline tumors and stage I carcinomas.Semantic proximity Read ↗

Mutation of K-ras protooncogene in human ovarian epithelial tumors of borderline malignancy.Semantic proximity Read ↗

TP53 and ovarian cancer.Semantic proximity Read ↗

Somatic BAP1 Loss in Ovarian Serous Borderline Tumor and Recurrent Low-grade Serous Carcinoma From a Germline BAP1 Mutation Carrier.Semantic proximity Read ↗

The clinical significance of mutations of the P53 tumour suppressor gene in haematological malignancies.Semantic proximity Read ↗

Molecular characterization of 103 ovarian serous and mucinous tumors.Semantic proximity Read ↗

Comparison of mutations of Ki-RAS and p53 immunoreactivity in borderline and malignant epithelial ovarian tumors.Semantic proximity Read ↗

Patterns of p53 mutations separate ovarian serous borderline tumors and low- and high-grade carcinomas and provide support for a new model of ovarian carcinogenesis: a mutational analysis with immunohistochemical correlation.Semantic proximity Read ↗

The p53 tumor-suppressor gene in human breast cancer.Semantic proximity Read ↗

Tumor-specific p53 sequences in blood and peritoneal fluid of women with epithelial ovarian cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.